GUGGENHEIM CAPITAL LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$548,000
-57.3%
14,558
-75.1%
0.00%
+33.3%
Q4 2017$1,284,000
-54.3%
58,501
-14.8%
0.00%
-57.1%
Q3 2017$2,810,000
+34.1%
68,636
-1.4%
0.01%
+16.7%
Q2 2017$2,096,000
+1.0%
69,643
+21.3%
0.01%0.0%
Q1 2017$2,075,000
-15.4%
57,409
+17.3%
0.01%
-14.3%
Q4 2016$2,452,000
-11.3%
48,938
-7.1%
0.01%
-22.2%
Q3 2016$2,765,000
+14.9%
52,677
-9.5%
0.01%
+12.5%
Q2 2016$2,407,00058,1990.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,092,152$16,808,219,0009.64%
GREAT POINT PARTNERS LLC 1,226,785$18,880,0007.47%
Ghost Tree Capital, LLC 500,000$7,695,0003.46%
RTW INVESTMENTS, LP 713,954$10,988,0003.41%
ARMISTICE CAPITAL, LLC 506,000$7,787,0002.66%
EcoR1 Capital, LLC 149,000$2,293,0001.04%
Eventide Asset Management 1,164,900$17,928,0001.04%
Telemetry Investments, L.L.C. 102,500$1,577,0000.68%
J. Goldman & Co LP 313,527$4,825,0000.41%
AWM Investment Company, Inc. 118,199$1,819,0000.35%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders